AVEO Oncology (NASDAQ: AVEO) and CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE